CervoMed is trading at $1.64, up 5.13%; broad market strength may be a backdrop, but no source directly links it to the after-hours move.
- No November 4 company release appears on CervoMedβs investor-relations news page; its latest listed release is dated October 29.
- Supplied market context reports major U.S. indices rose more than 1.7% on November 4.
- After-hours volume was not verified.